Evidence map›Paper›PMID 34149708›Full record

ArticleFrontiers in immunology2021

Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment.

Farida Benhadou, Violette Dirix, Fanny Domont, Fabienne Willaert, Anne Van Praet, Camille Locht, Françoise Mascart, Véronique Corbière

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Farida BenhadouDermatology Department, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Violette DirixLaboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Fanny DomontLaboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Fabienne WillaertDermatology Department, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Anne Van PraetLaboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Camille LochtUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
Françoise MascartLaboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Véronique CorbièreLaboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a skin inflammatory condition for which significant progress has been made in its management by the use of targeted biological drugs. Detection of latent

Indexed as

PsoriasisAdultFemaleHumansIncidenceInterferon-gamma Release TestsLatent TuberculosisMaleMiddle AgedRisk AssessmentTuberculin TestTumor Necrosis Factor InhibitorsTumor Necrosis Factor Inhibitorsheparin-binding haemagglutinininterferon-γ-release assayslatent tuberculosis infectionpsoriasisQuantiFERONtuberculin skin testsTumor necrosis factor-α inhibitors

Identifiers

PMID34149708
PMCPMC8209474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.